All
Oncotype DX predicts recurrence with aromatase inhibitor treatment
December 13th 2008A brief summarizing significant news from this year's San Antonio Breast Cancer Symposium regarding the TransATAC study's results showing that Oncotype DX may now be available for use in women who have taken aromatase inhibitors.
SABCS 2008 Marks the First Year of Collaboration
December 11th 2008The American Association of Cancer Research has joined the Cancer Therapy Research Center at the University of Texas Health Science Center at San Antonio, and the Baylor College of Medicine in putting on this year's San Antonio Breast Cancer Symposium.